Alterome Therapeutics raises $132 million in Series B led by Goldman Sachs Alternatives
SAN DIEGO: Alterome Therapeutics, Inc., a trailblazer in the biopharmaceutical industry, has successfully completed a Series B financing round, raising a substantial $132 million. This...
H2U raises over $10 million in Series B funding, aims to become Asia’s digital health unicorn
H2U, Taiwan’s leading digital health brand, announced that it has raised over 10 million USD in its Series B round of funding before the lunar...